Fracture Prevalence Among Human Immunodeficiency Virus (HIV)-infected Versus Non-HIV-infected Patients in a Large U.S. Healthcare System

Overview

Journal J Clin Endocrinol Metab

Publisher Oxford University Press

Specialty Endocrinology

Date 2008 Jul 3

PMID 18593764

Citations 220

Authors

Virginia A Triant

Todd T Brown

Hang Lee

Steven K Grinspoon

Affiliations

Soon will be listed here.

Abstract

Context: Reduced bone mineral density has been demonstrated among HIV-infected patients, but fracture prevalence is unknown.

Objective: The objective of the study was to compare fracture prevalence in HIV-infected and non-HIV-infected patients.

Design: This was a population-based study.

Setting: The study was conducted at a large U.S. health care system.

Patients: A total of 8525 HIV-infected and 2,208,792 non-HIV-infected patients with at least one inpatient or outpatient encounter between October 1, 1996, and March 21, 2008, was compared.

Main Outcome Measure: Fracture prevalence using specific International Classification of Diseases, Ninth Revision, Clinical Modification fracture codes was measured.

Results: The overall fracture prevalence was 2.87 vs. 1.77 patients with fractures per 100 persons in HIV-infected, compared with non-HIV-infected patients (P < 0.0001). Among females, the overall fracture prevalence was 2.49 vs. 1.72 per 100 persons in HIV-infected vs. non-HIV-infected patients (P = 0.002). HIV-infected females had a higher prevalence of vertebral (0.81 vs. 0.45; P = 0.01) and wrist (1.31 vs. 0.83; P = 0.01) fractures per 100 persons, compared with non-HIV-infected females but had a similar prevalence of hip fractures (0.47 vs. 0.56; P = 0.53). Among males, the fracture prevalence per 100 persons was higher in HIV-infected vs. non-HIV-infected patients for any fracture (3.08 vs. 1.83; P < 0.0001), vertebral fractures (1.03 vs. 0.49; P < 0.0001), hip fractures (0.79 vs. 0.45; P = 0.001), and wrist fractures (1.46 vs. 0.99; P = 0.001). Fracture prevalence was higher relative to non-HIV-infected patients among African-American and Caucasian females and Caucasian males.

Conclusions: Fracture prevalence is increased in HIV-infected compared with non-HIV-infected patients.

Citing Articles

Urgent focus on enhanced recovery after surgery of AIDS patients with limb fractures.

Li K, Zhang Q Bone Joint Res. 2024; 13(11):647-658.

PMID: 39530173 PMC: 11555538. DOI: 10.1302/2046-3758.1311.BJR-2024-0247.R1.

Prevalence and associated factors of low bone mineral density in people living with HIV: a cross-sectional study.

Shao Y, Sun J, Kong K, Zhang R, Zhang R, Liu L Arch Osteoporos. 2024; 19(1):56.

PMID: 38954143 DOI: 10.1007/s11657-024-01413-3.

Update on acquired hypogonadism in men living with HIV: pathogenesis, clinic, and treatment.

De Vincentis S, Rochira V Front Endocrinol (Lausanne). 2023; 14:1201696.

PMID: 37455928 PMC: 10338827. DOI: 10.3389/fendo.2023.1201696.

Subtrochanteric Pathological Femur Fracture in an HIV-Positive Patient on Tenofovir-based antiretroviral therapy: A Case Report and Review of the Literature.

Choudhary S, Rangasamy K, Naidu S, Sachdeva R, Sharma A J Orthop Case Rep. 2023; 13(2):14-20.

PMID: 37144071 PMC: 10152932. DOI: 10.13107/jocr.2023.v13.i02.3538.

Joint replacement and human immunodeficiency virus.

Salimi M, Mirghaderi P, Mosalamiaghili S, Mohammadi A, Salimi A World J Virol. 2023; 12(1):1-11.

PMID: 36743660 PMC: 9896588. DOI: 10.5501/wjv.v12.i1.1.

References

Prior J, Burdge D, Maan E, Milner R, Hankins C, Klein M . Fragility fractures and bone mineral density in HIV positive women: a case-control population-based study. Osteoporos Int. 2007; 18(10):1345-53. DOI: 10.1007/s00198-007-0428-7. View

Amiel C, Ostertag A, Slama L, Baudoin C, Nguyen T, Lajeunie E . BMD is reduced in HIV-infected men irrespective of treatment. J Bone Miner Res. 2004; 19(3):402-9. DOI: 10.1359/JBMR.0301246. View

Arnsten J, Freeman R, Howard A, Floris-Moore M, Lo Y, Klein R . Decreased bone mineral density and increased fracture risk in aging men with or at risk for HIV infection. AIDS. 2007; 21(5):617-23. PMC: 2426821. DOI: 10.1097/QAD.0b013e3280148c05. View

Brown T, Qaqish R . Antiretroviral therapy and the prevalence of osteopenia and osteoporosis: a meta-analytic review. AIDS. 2006; 20(17):2165-74. DOI: 10.1097/QAD.0b013e32801022eb. View

Huang J, Rietschel P, Hadigan C, Rosenthal D, Grinspoon S . Increased abdominal visceral fat is associated with reduced bone density in HIV-infected men with lipodystrophy. AIDS. 2001; 15(8):975-82. DOI: 10.1097/00002030-200105250-00005. View

Felsenberg D, Silman A, Lunt M, Armbrecht G, Ismail A, Finn J . Incidence of vertebral fracture in europe: results from the European Prospective Osteoporosis Study (EPOS). J Bone Miner Res. 2002; 17(4):716-24. DOI: 10.1359/jbmr.2002.17.4.716. View

Rivas P, Gorgolas M, Garcia-Delgado R, Diaz-Curiel M, Goyenechea A, Fernandez-Guerrero M . Evolution of bone mineral density in AIDS patients on treatment with zidovudine/lamivudine plus abacavir or lopinavir/ritonavir. HIV Med. 2007; 9(2):89-95. DOI: 10.1111/j.1468-1293.2007.00525.x. View

Dolan S, Carpenter S, Grinspoon S . Effects of weight, body composition, and testosterone on bone mineral density in HIV-infected women. J Acquir Immune Defic Syndr. 2007; 45(2):161-7. DOI: 10.1097/QAI.0b013e31804a7f4d. View

Cauley J, Hochberg M, Lui L, Palermo L, Ensrud K, Hillier T . Long-term risk of incident vertebral fractures. JAMA. 2008; 298(23):2761-7. DOI: 10.1001/jama.298.23.2761. View

10.

Gold J, Pocock N, Li Y . Bone mineral density abnormalities in patients with HIV infection. J Acquir Immune Defic Syndr. 2002; 30(1):131-2. DOI: 10.1097/00042560-200205010-00020. View

11.

Yin M, Dobkin J, Brudney K, Becker C, Zadel J, Manandhar M . Bone mass and mineral metabolism in HIV+ postmenopausal women. Osteoporos Int. 2005; 16(11):1345-52. PMC: 3108020. DOI: 10.1007/s00198-005-1845-0. View

12.

Caron M, Auclairt M, Vissian A, Vigouroux C, Capeau J . Contribution of mitochondrial dysfunction and oxidative stress to cellular premature senescence induced by antiretroviral thymidine analogues. Antivir Ther. 2008; 13(1):27-38. View

13.

Mondy K, Yarasheski K, Powderly W, Whyte M, Claxton S, DeMarco D . Longitudinal evolution of bone mineral density and bone markers in human immunodeficiency virus-infected individuals. Clin Infect Dis. 2003; 36(4):482-90. DOI: 10.1086/367569. View

14.

Gage B, Birman-Deych E, Radford M, Nilasena D, Binder E . Risk of osteoporotic fracture in elderly patients taking warfarin: results from the National Registry of Atrial Fibrillation 2. Arch Intern Med. 2006; 166(2):241-6. DOI: 10.1001/archinte.166.2.241. View

15.

Dolan S, Huang J, Killilea K, Sullivan M, Aliabadi N, Grinspoon S . Reduced bone density in HIV-infected women. AIDS. 2004; 18(3):475-83. DOI: 10.1097/00002030-200402200-00014. View

16.

Bongiovanni M, Fausto A, Cicconi P, Menicagli L, Melzi S, Ligabo V . Osteoporosis in HIV-infected subjects: a combined effect of highly active antiretroviral therapy and HIV itself?. J Acquir Immune Defic Syndr. 2005; 40(4):503-4. DOI: 10.1097/01.qai.0000184861.26733.8c. View

17.

Jones S, Restrepo D, Kasowitz A, Korenstein D, Wallenstein S, Schneider A . Risk factors for decreased bone density and effects of HIV on bone in the elderly. Osteoporos Int. 2007; 19(7):913-8. DOI: 10.1007/s00198-007-0524-8. View

18.

Bruera D, Luna N, David D, Bergoglio L, Zamudio J . Decreased bone mineral density in HIV-infected patients is independent of antiretroviral therapy. AIDS. 2003; 17(13):1917-23. DOI: 10.1097/00002030-200309050-00010. View

19.

Carr A, Miller J, Eisman J, Cooper D . Osteopenia in HIV-infected men: association with asymptomatic lactic acidemia and lower weight pre-antiretroviral therapy. AIDS. 2001; 15(6):703-9. DOI: 10.1097/00002030-200104130-00005. View

20.

Guaraldi G, Ventura P, Albuzza M, Orlando G, Bedini A, Amorico G . Pathological fractures in AIDS patients with osteopenia and osteoporosis induced by antiretroviral therapy. AIDS. 2001; 15(1):137-8. DOI: 10.1097/00002030-200101050-00025. View